Gunnar Sæter

Image of Gunnar Sæter
Norwegian version of this page
Mobile phone +47-22781402, +47-97031845
Username
Visiting address Forskningsveien 2 A OUS Rikshospitalet 0372 Oslo
Postal address Postboks 4950 Nydalen OUS, Rikshospitalet 0424 Oslo

Publications

  • Wind, Anke; Oberst, Simon; Westerhuis, Willien; Blaauwgeers, Harriet; Sæter, Gunnar & de Paoli, Paolo [Show all 11 contributors for this article] (2023). Evaluating comprehensive cancer networks; a review of standards and evaluation methods for care networks to inform a comparison with the OECI comprehensive cancer network standards. Acta Oncologica. ISSN 0284-186X. 62(1), p. 15–24. doi: 10.1080/0284186X.2023.2170275. Full text in Research Archive
  • Kehrloesser, Sebastian; Oberst, Simon; Westerhuis, Willien; Wendler, Astrid; Wind, Anke & Blaauwgeers, Harriët [Show all 25 contributors for this article] (2021). Analysing the attributes of Comprehensive Cancer Centres and Cancer Centres across Europe to identify key hallmarks. Molecular Oncology. ISSN 1574-7891. 15(5), p. 1277–1288. doi: 10.1002/1878-0261.12950.
  • Stark, Dan P.H.; Bielack, Stefan S.; Brugieres, Laurence; Dirksen, Uta; Duarte, Ximo & Dunn, Siobhan [Show all 24 contributors for this article] (2016). Teenagers and young adults with cancer in Europe: From national programmes to a European integrated coordinated project. European Journal of Cancer Care. ISSN 0961-5423. 25(3), p. 419–427. doi: 10.1111/ecc.12365.
  • Ohnstad, Hege Oma; Bruland, Øyvind; Taksdal, Ingeborg ; Bjerkehagen, Bodil; Nenadovic, Maja & Sæter, Gunnar [Show all 8 contributors for this article] (2014). Response to preoperative chemotherapy in patients undergoing resection of pulmonary metastasis from soft tissue sarcoma - A predictor of outcome? Acta Oncologica. ISSN 0284-186X. 53(9), p. 1180–1187. doi: 10.3109/0284186X.2014.899433.
  • Pedersen, Kjetil Boye; Del Prever, Adalberto Brach; Eriksson, Mikael; Sæter, Gunnar; Tienghi, Amelia & Lindholm, Paula [Show all 10 contributors for this article] (2014). High-dose chemotherapy with stem cell rescue in the primary treatment of metastatic and pelvic osteosarcoma: Final results of the ISG/SSG II study. Pediatric Blood & Cancer. ISSN 1545-5009. 61(5), p. 840–845. doi: 10.1002/pbc.24868.
  • Namløs, Heidi Maria; Kresse, Stine Henrichson; Muller, Christoph Rainer; Henriksen, Jørn; Holdhus, Rita & Sæter, Gunnar [Show all 10 contributors for this article] (2012). Global gene expression profiling of human osteosarcomas reveals metastasis-associated chemokine pattern. Sarcoma. ISSN 1357-714X. doi: 10.1155/2012/639038.
  • Muller, Christoph Rainer; Namløs, Heidi Maria; Bjerner, Johan; Østensen, Ingrid Helene Garmann; Sæter, Gunnar & Smeland, Sigbjørn [Show all 8 contributors for this article] (2010). Characterization of Treatment Response to Recombinant Interferon-α2b in Osteosarcoma Xenografts. Journal of Cancer Science & Therapy. ISSN 1948-5956. 2(1), p. 16–25. doi: 10.4172/1948-5956.1000018.
  • Bjerkehagen, Bodil; Smeland, Sigbjørn; Walberg, Lise; Skjeldal, Sigmund; Hall, Kirsten Sundby & Nesland, Jahn M [Show all 9 contributors for this article] (2008). Radiation-induced sarcoma: 25-year experience from the Norwegian Radium Hospital. Acta Oncologica. ISSN 0284-186X. 47(8), p. 1475–1482. doi: 10.1080/02841860802047387.
  • Bruland, Øyvind; Høifødt, Hanne Kleppe; Sæter, Gunnar; Smeland, Sigbjørn & Fodstad, Øystein (2005). Hematogenous micrometastases in osteosarcoma patients. Clinical Cancer Research. ISSN 1078-0432. 11, p. 4666–4673.
  • Micci, F.; Walter, CU; Teixeira, Manuel Antonio R.; Panagopoulos, I; Bjerkehagen, Bodil & Sæter, Gunnar [Show all 7 contributors for this article] (2003). Cytogenetic and molecular genetic analyses of endometrial stromal sarcoma: Nonrandom involvement of chromosome arms 6p and 7p and confirmation of JAZF1/JJAZ1 gene fusion in t(7;17). Cancer Genetics and Cytogenetics. ISSN 0165-4608. 144(2), p. 119–124.
  • Skotheim, Rolf Inge; Kallioniemi, Anne; Bjerkhagen, Bodil; Mertens, Fredrik; Brekke, Helge R & Monni, Outi [Show all 13 contributors for this article] (2003). Topoisomerase-II alfa is upregulated in malignant peripheral nerve sheath tumors and associated with clinical outcome. Journal of Clinical Oncology. ISSN 0732-183X. 21, p. 4586–4591.
  • Skotheim, Rolf Inge; Kallioniemi, A; Bjerkehagen, Bodil; Mertens, F; Brekke, HR & Monni, O [Show all 13 contributors for this article] (2003). Topoisomerase-II alpha is upregulated in malignant peripheral nerve sheath tumors and associated with clinical outcome. Journal of Clinical Oncology. ISSN 0732-183X. 21, p. 4586–4591.

View all works in Cristin

Published Aug. 20, 2013 12:33 PM - Last modified June 4, 2014 12:53 PM